From Scientific Discovery to Patient Impact

 

We bring together researchers, clinicians and industry partners to advance new treatments.

A*STAR supports promising discoveries across the research and development journey, connecting the scientific, translational and commercial capabilities needed to move them towards clinical development, commercialisation and venture creation.

Discover

Bring together scientific innovation and clinical insights to uncover novel disease drivers and identify promising therapeutic targets and approaches.

Develop

Accelerate translation of promising discoveries into tractable therapies through validation, optimisation and preclinical development.

Advance

Progress the strongest assets towards clinical impact through industry partnerships and venture creation.

Focus Areas

 

We focus on health areas where we have distinctive scientific and clinical capabilities, and Singapore is well-placed to make a global impact.

astar-image-placeholder

Eye Health

Advancing new therapies for retinal diseases, including age-related macular degeneration and inherited retinal diseases.

astar-image-placeholder

Skin Health

Deepening the understanding and treatment of immune-related skin conditions, including atopic dermatitis, vitiligo and age-related skin conditions.

astar-image-placeholder

Heart and Metabolic Health

Developing novel therapies for cardiovascular and metabolic diseases, including obesity, liver fibrosis and heart failure.

astar-image-placeholder

Brain Health

Discovering new approaches for neurodegenerative diseases, including ALS and age-related cognitive decline.

astar-image-placeholder

Immunity and Inflammation

Translating immunological insights into potential treatments for inflammatory and autoimmune diseases.

astar-image-placeholder

Cancer

Pushing the frontiers of cancer research to uncover novel biology and develop the next generation of cancer therapies.

Bringing Together Ecosystem Capabilities to Advance Scientific Discoveries into Novel Therapies

 

A*STAR’s national programmes connect scientific discovery with the specialist capabilities across the ecosystem needed for researchers and industry partners to accelerate the development of the promising therapeutic innovations.

astar-image-placeholder

AI in Drug Discovery (AIDD)

 

Harnesses AI to discover new therapeutic targets and design better drug candidates, accelerating the journey from novel biology to promising medicines.

astar-image-placeholder

Nucleic Acid Therapeutics Initiative (NATi)

 

Accelerates translation of RNA therapeutics through end-to-end capabilities spanning RNA design and synthesis, targeted delivery, and preclinical drug development.

astar-image-placeholder

Experimental Drug Development Centre (EDDC)

 

Transforms promising small molecule and biologic drug candidates into differentiated novel therapies, enabling commercial translation through industry partnerships and creation of spinoffs.

astar-image-placeholder

Biomanufacturing Technology & Partnership (BioTAP)

 

Advancing industry-driven R&D and innovation to strengthen Singapore’s biomanufacturing capabilities and competitiveness.

astar-image-placeholder

A*STAR Entrepreneur Partners Programme (EPP) – Therapeutics Track

 

The therapeutics track of the A*STAR Entrepreneur Partners Programme (EPP) harnesses experienced entrepreneurial expertise to shape promising therapeutic innovations. Entrepreneur Partners leverage their industry experience, professional and investor networks to guide development strategies and create pathways towards new biotech venture creation.

Together, our national programmes bring together the specialised capabilities needed to turn scientific discoveries into therapeutic assets with the potential for global impact.

 

Let’s Advance the Next Breakthrough Together

Partner with A*STAR to access industry-leading scientific expertise, robust translational capabilities, and a powerful network designed to accelerate the development of promising therapies.

Collaborate with us

Tell us about your organisation, area of interest, the type of collaboration you are exploring and where you’ve heard about us.